Innovation Research entered the industry of Mail Order Pharmaceuticals in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 454113, which describes it as a Mail Order Pharmaceuticals. For further clarification, the SIC classifies this business under the code 5961 and described it as a Mail Order Pharmaceuticals. The business provides service to the B2C market.
To acquire more information, please contact Peter Vancea by calling No number given during business hours. You can also write to the business’ Single Location at 3142 East Acoma Drive, Phoenix, Arizona AZ 85032. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Innovation Research |
| Representative: | Peter Vancea |
| Place of Business: | 3142 East Acoma Drive, Phoenix, AZ 85032 |
| Contact Number: | No number given |
| Type of Service: | Mail Order Pharmaceuticals |
| SIC Number: | 5961 |
| NAICS Number: | 454113 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2001 |
| Income/Year: | $50.000 to $99.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Innovation Research is a company operating from Maricopa, Arizona providing professional Mail Order Pharmaceuticals and relevant B2C variables. It was founded in 2001 and registered with the SIC code 5961 as Mail Order Pharmaceuticals, and with the NAICS code 454113 as Mail Order Pharmaceuticals.
With a current employee count of 1 to 4, Innovation Research has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Peter Vancea at No number given for related queries, or to locate its Single Location using the coordinates 33.668722,-112.137658.
The Single Location can also be found at the street address 3142 East Acoma Drive in Phoenix, Arizona 85032 and can be engaged online through the company website at , the company Twitter , and Facebook page .